Replies to post #1098 on BioCardia Inc (BCDA)

[realfast95]

never mind. I found what I wanted in the 10K

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11966159

Our FDA accepted Phase III pivotal trial is designed to provide the primary support for the safety and efficacy of CardiAMP. The primary endpoint is functional capacity, as measured by the six minute walk test. Based on the results achieved in the Phase II trial, our Phase III pivotal trial is designed to have more than 90% probability of achieving a positive result with statistical significance. Statistical significance denotes the mathematical likelihood that the results observed are real and not due to chance.